Agency Profile

IONTOX

Kalamazoo, United States

Overview

IONTOX’s comprehensive cytotoxicity screening studies aim to identify the EC50/ lowest observed adverse effect concentration. Most of our screening assays utilize fluorescence or luminescence analysis to deliver % cytotoxic or viable cells. Cell viability can further be assessed by measuring the amount of ATP. To get more information, visit our website today!

Sponsorship in April 2026

REVIEW(S)

$(document).ready(function () { $('.popup-youtube').magnificPopup({ //disableOn: 700, type: 'iframe', mainClass: 'mfp-fade', removalDelay: 160, preloader: false, fixedContentPos: false }); });